Turnstone Biologics's long-term debt is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Turnstone Biologics (TSBX) currently reports a long-term debt of $0 as of June 2025. That compares with $410K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Turnstone Biologics's long-term debt history and peer comparisons.
Turnstone Biologics's long-term debt decreased from $410K to $0 — a 100.0% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Turnstone Biologics reported $0 in long-term debt as of June 2025. That compares with $410K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Turnstone Biologics, and consider following TSBX for alerts when major investors trade the stock.